27 related articles for article (PubMed ID: 832224)
1. [Veno-occlusive syndrome with acute liver dystrophy following decarbazine therapy of malignant melanoma (author's transl)].
Voigt H; Caselitz J; Jänner M
Klin Wochenschr; 1981 Mar; 59(5):229-36. PubMed ID: 7218735
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of AMSA alone and in combination with DTIC in patients with metastatic melanoma.
Polyzos A; Legha SS; Burgess AM; Benjamin RS; Bodey GP
Invest New Drugs; 1988 Apr; 6(1):57-61. PubMed ID: 3410667
[TBL] [Abstract][Full Text] [Related]
3. Appropriate and inappropriate neuroendocrine products in pulmonary tumourlets.
Gosney J; Green AR; Taylor W
Thorax; 1990 Sep; 45(9):679-83. PubMed ID: 2145655
[TBL] [Abstract][Full Text] [Related]
4. Vindesine as a single agent in the treatment of advanced malignant melanoma.
Retsas S; Newton KA; Westbury G
Cancer Chemother Pharmacol; 1979; 2(4):257-60. PubMed ID: 455584
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy of malignant melanoma.
Benjamin RS
World J Surg; 1979 Jul; 3(3):321-8. PubMed ID: 382646
[No Abstract] [Full Text] [Related]
6. [DTIC in malignant melanoma: a perspective (author's transl)].
Kokoschka EM
Wien Klin Wochenschr; 1978 Dec; 90(24):870-4. PubMed ID: 369152
[TBL] [Abstract][Full Text] [Related]
7. Bis chloroethyl nitrosourea, vincristine, dimethyl triazeno imidazole carboxamide and chlorpromazine combination chemotherapy in disseminated malignant melanoma.
McKelvey EM; Luce JK; Vaitkevicius VK; Talley RW; Bodey GP; Lane M; Moon TE
Cancer; 1977 Jan; 39(1):5-10. PubMed ID: 832251
[TBL] [Abstract][Full Text] [Related]
8. A clinical trial of procarbazine plus vincristine plus bis-chloroethyl-nitrosourea plus imidazole carboxamide dimethyl triazeno in metastatic malignant melanoma.
Van Dyk JJ; Falkson G
Med Pediatr Oncol; 1975; 1(2):107-11. PubMed ID: 1228411
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and vincristine with two dose schedules of 5-(3,3-dimethyl-1-triazino) imidazole 4-carboxamide (DTIC) in the treatment of disseminated malignant melanoma.
Moon JH; Gailani S; Cooper MR; Hayes DM; Rege VB; Blom J; Falkson G; Maurice P; Brunner K; Glidewell O; Holland JF
Cancer; 1975 Feb; 35(2):368-71. PubMed ID: 1111913
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy of malignant melanoma with imidazole carboxamide, BCNU and vincristine.
Cohen SM; Greenspan EM; Ratner LH; Weiner MJ
Cancer; 1977 Jan; 39(1):41-4. PubMed ID: 832250
[TBL] [Abstract][Full Text] [Related]
11. [Polychemotherapy with 5-(3,3 dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC; NSC-45388), 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC-409962) and vincristine (NSC-67574) in the metastatic phase of melanoma].
Beretta G; Bajetta E; Bonadonna G; Tancini G; Orefice S; Veronesi U
Tumori; 1973; 59(3):239-48. PubMed ID: 4729646
[No Abstract] [Full Text] [Related]
12. Combination chemotherapy with bis chloroethyl nitrosourea (BCNU), vincristine and dimethyl triazeno imidazole carboxamide (DTIC) in disseminated malignant melanoma.
McKelvey EM; Luce JK; Talley RW; Hersh EM; Hewlett JS; Moon TE
Cancer; 1977 Jan; 39(1):1-4. PubMed ID: 832224
[TBL] [Abstract][Full Text] [Related]
13. DTIC (NSC-45388) in malignant melanoma: a perspective.
Comis RL
Cancer Treat Rep; 1976 Feb; 60(2):165-76. PubMed ID: 769969
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]